Unknown

Dataset Information

0

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy.

ABSTRACT:

SUBMITTER: Takahashi K 

PROVIDER: S-EPMC9724979 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy.

Takahashi Kuniaki K   Thuijs Daniel J F M DJFM   Hara Hironori H   Wang Rutao R   Mohr Friedrich-Wilhelm FW   Morice Marie-Claude MC   Holmes David R DR   Kappetein Arie Pieter AP   Head Stuart J SJ   Onuma Yoshinobu Y   Serruys Patrick W PW  

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20210501 1

Similar Datasets

Unknown Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study.
| S-EPMC8484131 | biostudies-literature
Unknown Dietary acid load significantly predicts 10-years survival in patients underwent coronary artery bypass grafting (CABG) surgery.
| S-EPMC6797202 | biostudies-literature
Unknown CCTA-based CABG SYNTAX Score: a tool to evaluate completeness of coronary segment revascularization after bypass surgery.
| S-EPMC10692266 | biostudies-literature
Unknown Residual SYNTAX score and outcomes after TAVR+PCI versus SAVR+CABG: a propensity-matched, gender-based comparison.
| S-EPMC12496072 | biostudies-literature
Unknown Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial.
| S-EPMC8483455 | biostudies-literature
Unknown 10 Years of SYNTAX: Closing an Era of Clinical Research After Identifying New Outcome Determinants.
| S-EPMC10308124 | biostudies-literature
Unknown Impacts of the SYNTAX score I, II and SYNTAX score II 2020 on left main revascularization.
| S-EPMC10784526 | biostudies-literature
Unknown Utilization and Cost Analysis of Lung Transplantation and Survival After 10 Years of Adapting the Lung Allocation Score.
| S-EPMC6200665 | biostudies-literature
Unknown Clinical treatment score post-5 years and survival benefit from extended endocrine therapy for breast cancer patients under and over 50 years of age.
| S-EPMC12031770 | biostudies-literature
Unknown Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended Survival study.
| S-EPMC8238698 | biostudies-literature